NCT02280603

Clinical Trial to Explore the Efficacy and Safety of DA-4001 After Topical Application

A Single-center, Active-controlled, Randomized, Double-blind, Proof of Concept Clinical Trial to Explore the Efficacy and Safety of DA-4001 After Topical Application in Male Patients With Androgenetic Alopecia

• Status: Completed
• Phase: Phase 1 / Phase 2
• Study type: Interventional
• Enrollment: 60 (actual)
• Sponsor: Dong-A ST Co., Ltd. · Industry
• Sex: Male
• Age: 18 Years – 49 Years
• Healthy volunteers: Not accepted

Summary

This study is designed to explore the efficacy and safety of DA-4001 after topical application in male patients with androgenetic alopecia Design : Randomized, double-blind, active-controlled study Investigational Product : Finasteride, minoxidil

Conditions

• Androgenetic Alopecia

Interventions

Type	Name	Description
DRUG	DA-4001C	1ml by topical application twice a day
DRUG	5% minoxidil	1ml by topical application twice a day

Timeline

• Start date: 2014-01-01
• Primary completion: 2014-12-01
• Completion: 2014-12-01
• First posted: 2014-10-31
• Last updated: 2015-06-24

Locations

1 site across 1 country: South Korea